Alkem Laboratories' Stock Reaches All-Time High, Outperforms Sector and Sensex

Aug 11 2024 09:20 AM IST
share
Share Via
Alkem Laboratories, a leading pharmaceutical company, has been making headlines in the stock market with its recent performance. On August 11, 2024, the stock reached an all-time high of Rs. 5849, surpassing its previous 52-week high. This has caught the attention of MarketsMojo, which has given a 'Buy' call for the stock. Alkem Laboratories has also outperformed the sector by 1.94% and has been on a consecutive gain for the last 3 days, with a 10.31% increase in returns. The stock's volatility and potential for growth are evident from its intraday high and low of Rs. 5849 and Rs. 5515.3 respectively. With a strong upward trend and impressive 1-year performance of 38.40%, Alkem Laboratories is a top performer in the pharma industry. Its consistent growth and strong financials make it a promising investment option in the largecap sector.
Alkem Laboratories' Stock Reaches All-Time High, Outperforms Sector and Sensex
Alkem Laboratories, a leading pharmaceutical company in the largecap industry, has been making waves in the stock market with its recent performance. On August 11, 2024, the company's stock price reached an all-time high of Rs. 5849, breaking its previous 52-week high. This impressive performance has caught the attention of MarketsMOJO, a renowned stock market analysis platform, which has given a 'Buy' call for Alkem Laboratories. The stock has also outperformed the sector by 1.94% and has been on a consecutive gain for the last 3 days, with a 10.31% increase in returns during this period. The stock's intraday high of Rs. 5849 and low of Rs. 5515.3 also showcase its volatility and potential for growth. Alkem Laboratories is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. In comparison to the Sensex's performance of 20.77%, Alkem Laboratories has shown a remarkable 1-year performance of 38.40%. This further solidifies the company's position as a top performer in the pharma industry. With its consistent growth and strong financials, Alkem Laboratories is a promising investment option for those looking to invest in the largecap sector. As the company continues to make strides in the pharmaceutical industry, investors can expect to see even more positive results in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News